The antiphospholipid syndrome is an autoimmune disorder of hypercoagulability
characterized by the presence of autoantibodies to various phospholipids or phospholipid …

Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by the
aberrant production of a broad and heterogenous group of autoantibodies. Even though the …

Patients with COVID-19 are at high risk for thrombotic arterial and venous occlusions. Lung
histopathology often reveals fibrin-based blockages in the small blood vessels of patients …

Objective The objective of this paper is to conduct a systematic review and meta-analysis on
the risk of developing elevated antiphospholipid (aPL) antibodies and related …

It has long been appreciated that lipids, particularly anionic phospholipids, promote blood
coagulation. The last two decades have seen an increasing insight into the kinetic and …

Anticardiolipin antibodies (aCL) derived from the sera of individuals exhibiting the
antiphospholipid syndrome (APS) directly bind to beta 2-glycoprotein I (beta 2-GPI), which is …

Many infections have been found to be associated with antiphospholipid antibodies (aPL),
although a pathogenic role for these antibodies has not usually been obvious except in a …

Antiphospholipid antibodies (APA), lupus anticoagulant (LA) and/or anticardiolipin
antibodies (ACA), are associated with thrombosis and recurrent miscarriage. We studied the …

Two neutralizing human mAbs, 2F5 and 4E10, that react with the HIV-1 envelope gp41
membrane proximal region are also polyspecific autoantibodies that bind to anionic …

Background Data concerning the relation between anti-phospholipid (aPL) antibodies and
myocardial infarction in subjects without evidence of overt autoimmune disease are …